User profiles for M. Walsh

Michael Walsh

- Verified email at phri.ca - Cited by 23280

Michael F Walsh

- Verified email at mskcc.org - Cited by 11605

Michael Walsh

- Verified email at uwec.edu - Cited by 6109

2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American …

…, KJ Stewart, D Treat-Jacobson, ME Walsh - Journal of the American …, 2017 - jacc.org
The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of …

…, KJ Stewart, D Treat-Jacobson, ME Walsh - Circulation, 2017 - Am Heart Assoc
The recommendations listed in this guideline are, whenever possible, evidence based An
initial extensive evidence review, which included literature derived from research involving …

Necrotizing enterocolitis: treatment based on staging criteria

MC Walsh, RM Kliegman - Pediatric Clinics of North America, 1986 - Elsevier
Neonatal necrotizing enterocolitis is the most important cause of acquired gastrointestinal
morbidity or mortality among low birthweight infants. Prematurity alone is probably the only …

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 …

…, JT Van, JB Vazquez-Tanus, R Reyes, M Welch… - The Lancet, 2021 - thelancet.com
Background We aimed to assess efficacy and safety, with a special focus on cardiovascular
safety, of the novel dual GIP and GLP-1 receptor agonist tirzepatide versus insulin glargine …

Peripheral arterial disease detection, awareness, and treatment in primary care

…, SH Krook, DB Hunninghake, AJ Comerota, ME Walsh… - Jama, 2001 - jamanetwork.com
ContextPeripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis that
is common and is associated with an increased risk of death and ischemic events, yet may …

Quantum dot superlattice thermoelectric materials and devices

TC Harman, PJ Taylor, MP Walsh, BE LaForge - science, 2002 - science.org
PbSeTe-based quantum dot superlattice structures grown by molecular beam epitaxy have
been investigated for applications in thermoelectrics. We demonstrate improved cooling …

[HTML][HTML] Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

…, P van Paassen, D Walsh, M Walsh… - … England Journal of …, 2010 - Mass Medical Soc
… The median age was 68 years, and the glomerular filtration rate (GFR) was 18 ml per minute
per 1.73 m 2 of body-surface area. A total of 25 patients in the rituximab group (76%) and 9 …

Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012

BJ Stoll, NI Hansen, EF Bell, MC Walsh, WA Carlo… - Jama, 2015 - jamanetwork.com
Importance Extremely preterm infants contribute disproportionately to neonatal morbidity and
mortality. Objective To review 20-year trends in maternal/neonatal care, complications, and …

Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network

…, EF Bell, S Shankaran, AR Laptook, MC Walsh… - …, 2010 - publications.aap.org
OBJECTIVE: This report presents data from the Eunice Kennedy Shriver National Institute of
Child Health and Human Development Neonatal Research Network on care of and …

Outcomes of a field trial to improve children's dietary patterns and physical activity: The Child and Adolescent Trial for Cardiovascular Health (CATCH)

…, C Kannler, G Rennie, D Sellers, M Walsh, M Yang… - Jama, 1996 - jamanetwork.com
Objective. —To assess the outcomes of health behavior interventions, focusing on the
elementary school environment, classroom curricula, and home programs, for the primary …